0,014€
-25,78%
Echtzeit-Aktienkurs Hemogenyx Pharmaceuticals PLC
Bid:
Ask:
Echtzeit-Chart der Hemogenyx Pharmaceuticals PLC Aktie
Börsenkurse Hemogenyx Pharmaceuticals PLC
| Börse Stuttgart | - | - | - | - | 0,016€ | 14,29% |
| Echtzeit Euro | - | - | - | - | 0,014€ | -25,78% |
| Börse Frankfurt | - | - | - | - | 0,014€ | 18,75% |
Fundamentaldaten der Hemogenyx Pharmaceuticals PLC Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [GBP] | - | -6,70 Mio. | -6,69 Mio. | - | - | - | - |
| 2022 [GBP] | - | -3,99 Mio. | -3,98 Mio. | - | - | - | - |
| 2021 [GBP] | - | -5,11 Mio. | -5,10 Mio. | - | - | - | - |
| 2020 [GBP] | - | -2,10 Mio. | -2,08 Mio. | - | - | - | - |
| 2019 [GBP] | - | -1,49 Mio. | -1,45 Mio. | - | - | - | - |
| 2018 [GBP] | - | -1,52 Mio. | -1,48 Mio. | - | - | - | - |
| 2017 [GBP] | - | -2,41 Mio. | -2,36 Mio. | - | - | - | - |
| 2016 [GBP] | - | -1,00 Mio. | -1,00 Mio. | - | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Hemogenyx Pharmaceuticals PLC Aktie
HemoGenyx Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of a suite of products to address current problems associated with the treatment of blood disorders such as cancers and autoimmune diseases, with bone marrow, or hematopoietic stem cell, transplants, and with viral infections. It operates through the United Kingdom and United States geographical segments. The company was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.